ChemBriefSK Pharmteco unveils $200M investment plan to expand US infrastructure
SK Pharmteco announced a five-year, over $200 million investment to upgrade its US manufacturing infrastructure for small molecules and peptides. The plan includes new development labs and expanded GM
chemweek · 2026-10-05 13:12 UTC